Stocks
Adaptive Biotechnologies (ADPT) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -125.3% | -94.6% | -111.2% | -71.9% | -10.8% | -7.46% | ||
| Changes by years, y/y, % | +21pp | +31pp | -17pp | +39pp | +61pp | -40.7% | |||
Adaptive Biotechnologies. EBITDA margin, %
Adaptive Biotechnologies. EBITDA margin, changes, pp
Adaptive Biotechnologies (ADPT) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -56.4% | -30.8% | 18.0% | -8.97% | -20.3% | -7.46% | |
| Changes by years, y/y, % | +37pp | +58pp | +71pp | +46pp | +36pp | |||
| Changes by quarters, q/q, % | -1pp | +26pp | +49pp | -27pp | -11pp | |||
